ENDOmiARN Salive Test is a multicentre external validation study of a salivary signature of endometriosis carried out in France in Obstetrics and Reproductive Medicine departments, in order to evaluate its performance and discuss its use in clinical practice. The clinical application is to significantly reduce the time to diagnosis and improve the care pathway for endometriosis. The study population is made up of women aged 18 to 43 years with formally diagnosed endometriosis or suspected endometriosis who are already receiving either medical (MAP) or surgical treatment as part of their routine care. The patients concerned by the study are managed without any change in the care pathway, nor any change in the therapeutic indications, nor any change in the diagnostic examinations (imaging or biology) required according to the context, which are carried out in accordance with the HAS recommendations. In this study, the management and follow-up of patients : * Are not imposed by the study: the doctor remains free to make medical prescriptions (treatments and examinations) and to determine the interval between consultation visits, * Are not modified in comparison with the usual follow-up, except for the performance of : * Collection of saliva * Electronic collection of the answers to the questionnaires completed by the patient
Study Type
OBSERVATIONAL
Enrollment
1,140
CHU Québec
Québec, Canada
CHU Strasbourg - Hôpital Hautepierre
Strasbourg, Alsace, France
CHU de Caen
Caen, Calvados, France
Clinique Tivoli
Bordeaux, Gironde, France
CHU Toulouse - Hôpital Rangueil
Toulouse, Haute Garonne, France
Clinique Pasteur
Toulouse, Haute-Garonne, France
Clinique La Sagesse
Rennes, Ille Et Vilaine, France
Cabinet de Gynécologie Médicale
Lyon, Rhône, France
CHU Rouen
Bois-Guillaume, Seine-Maritime, France
Hôpital BICETRE
Le Kremlin-Bicêtre, Val De Marne, France
...and 8 more locations
At least a 90% Sensitivity (True Positive Rate) of Endometriosis diagnotic confirmation using a miRNA signature
External validation of the salivary signature of endometriosis miRNAs
Time frame: Through the end of study inclusions, an average of 1 year
At least a 90% Specificity (True Negative Rate) of Endometriosis diagnotic confirmation using a miRNA signature
External validation of the salivary signature of endometriosis miRNAs
Time frame: Through the end of study inclusions, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.